Greece vs Panama: Access to anti-retroviral drugs, female
Greece
57.0%
in 2024
Panama
55.0%
in 2024
Greece rank
108th
Panama rank
111th
Access to anti-retroviral drugs, female over time
- Greece
- Panama
How they compare
Greece currently reports 57.0% against 55.0% in Panama, a difference of 2.0%.
Across all 25 years both countries report, Greece has been ahead every year.
Greece ranks 108th and Panama ranks 111th of 141 countries.
Greece has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Greece | Panama | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 44.3% | 16.9% | 27.4% | Greece |
| 2010s | 49.7% | 40.8% | 8.9% | Greece |
| 2020s | 55.6% | 50.0% | 5.6% | Greece |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, female, Greece or Panama?
- Greece, at 57.0% against 55.0% in Panama as of 2024.
- What is the difference in access to anti-retroviral drugs, female between Greece and Panama?
- 2.0%, with Greece ahead.
- How many years of comparable data are there for Greece and Panama?
- 25 years are reported by both, from 2000 to 2024.
- How do Greece and Panama rank globally for access to anti-retroviral drugs, female?
- Greece ranks 108th and Panama ranks 111th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, female (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.